Please note that the English and Chinese versions of all corporate communications^(Note) of Shanghai Henlius Biotech, Inc. (the “Company”) are available on the Company’s website () and the website of The Stock Exchange of Hong Kong Limited ("HKEX”) (www.hkexnews.hk). Shareholders who wish to receive the corporate communication(s) in printed form may submit the request online to the Company by email at [email protected]. To receive instant notifications of the Company’s announcements, corporate communications and updates to HKEX website, shareholders can subscribe to the News Alerts Service by HKEX (https://www.hkex.com.hk/eng/invest/user/login_e.aspx) free of charge.

Note: “Corporate communication” means any document issued or to be issued by the Company, including but not limited to: (a) the directors’ report, its annual accounts together with a copy of the auditors’ report and, where applicable, its summary financial report; (b) the interim report and, where applicable, its summary interim report; (c) a notice of meeting; (d) a listing document; (e) a circular; and (f) a proxy form.